Wierda, W., Brown, J., Ghia, P., Roeker, L., Patel, K., Eyre, T., Munir, T., Lech-Maranda, E., Lamanna, N., Tam, C., Seymour, J., Tessoulin, B., Shah, N., Ujjani, C., Fakhri, B., Coombs, C., Flinn, I., Patel, M., Nasta, S. D., Cohen, J., Alencar, A., Cheah, C., Ma, S., Rhodes, J., Jagadeesh, D., Zinzani, P. L., Österborg, A., Izutsu, K., Fukuhara, N., Tsai, D., Abada, P., Balbas, M., Li, J., Wang, Y. (., Jurczak, W., Woyach, J. (2025). Pirtobrutinib in post-cbtki CLL/SLL: Final update from the Phase 1/2 BRUIN study with more than 5 years follow-up. Blood. https://doi.org/10.1182/blood-2025-2115